Overexpression of FGFs was reported, for instance, for FGF8 and FGF19 in hepatocellular carcinoma (HCC) [9, 10] and for FGF2 in multiple cancers including melanoma and mesothelioma [11, 12]. This evidence concerns the gene FGF2 and hepatocellular carcinoma.